To verify this, the HCC patients were divided into four sub-groups as follows: (i) GPX8-high and HSC70-high (n = 38); (ii) GPX8-high and HSC70-low (n = 197); (iii) GPX8-low and HSC70-high (n = 30); and (iv) GPX8-low and HSC70-low (n = 87). This evidence concerns the gene GPX8 and hepatocellular carcinoma.